𝔖 Bobbio Scriptorium

✦ LIBER ✦

Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study

✍ Scribed by Vesole, D H; Oken, M M; Heckler, C; Greipp, P R; Katz, M S; Jacobus, S; Morrow, G R

Book ID: 120366390
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 295 KB
Volume: 26
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2012.124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III randomized study of oral ver

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study

✍ William S. Dalton; John J. Crowley; Sydney S. Salmon; Thomas M. Grogan; Leslie R 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB

353 Oral Phase III multicenter randomize

353 Oral Phase III multicenter randomized study of concurrent twice-a-day continuous radiotherapy with and without Cisplatin-5FU chemotherapy (BiRCF) in locally advanced unresectable pharyngeal squamous-cell carcinoma. Preliminary results regarding feasibility, early tolerance and control at 6 months (FNCLCC-GORTEC)

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB